Reduction of lipophilicity at the lipophilic domain of RXR agonists enables production of subtype preference: RXRalpha-preferential agonist possessing a sulfonamide moiety. (Q46834294)
Jump to navigation
Jump to search
scientific article published in March 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Reduction of lipophilicity at the lipophilic domain of RXR agonists enables production of subtype preference: RXRalpha-preferential agonist possessing a sulfonamide moiety. |
scientific article published in March 2008 |
Statements
Reduction of lipophilicity at the lipophilic domain of RXR agonists enables production of subtype preference: RXRalpha-preferential agonist possessing a sulfonamide moiety (English)
Kayo Takamatsu
Atsushi Takano
Nobumasa Yakushiji
Ken-ichi Morishita
Nobuyasu Matsuura
Makoto Makishima
Hamed Ismail Ali
Eiichi Akaho
Akihiro Tai
Kenji Sasaki
1 March 2008
1 reference